Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (9), 2532-2534
- https://doi.org/10.1016/j.bmcl.2006.01.105
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Potent Inhibitors of Subgenomic Hepatitis C Virus RNA Replication through Optimization of Indole-N-Acetamide Allosteric Inhibitors of the Viral NS5B PolymeraseJournal of Medicinal Chemistry, 2005
- Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°Current Medicinal Chemistry - Anti-Infective Agents, 2005
- Current Antiviral Therapy for Chronic Hepatitis C Including Liver Transplantation and Hepatic ResectionCurrent Medicinal Chemistry - Anti-Infective Agents, 2003
- Hepatitis C therapeutics: current status and emerging strategiesNature Reviews Drug Discovery, 2002
- Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCVCurrent Medicinal Chemistry - Anti-Infective Agents, 2002
- Hepatitis C: an epidemiological reviewJournal of Viral Hepatitis, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- The Scientific Challenge of Hepatitis CScience, 1999
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989